Sertoli-Leydig Cell Tumor

Sertoli-Leydig Cell Tumor, also known as sertoli-leydig cell tumor of intermediate differentiation, is related to carcinoid tumors, intestinal and leydig cell tumor, and has symptoms including hoarseness An important gene associated with Sertoli-Leydig Cell Tumor is CALB2 (Calbindin 2), and among its related pathways/superpathways are COPI-independent Golgi-to-ER retrograde traffic and Cytoskeletal Signaling. The drugs Bevacizumab and Paclitaxel have been mentioned in the context of this disorder. Affiliated tissues include ovary and endothelial, and related phenotypes are Reduced mammosphere formation and normal